These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


321 related items for PubMed ID: 3309811

  • 1. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
    Soussy CJ, Deforges L, Le Van Thoi J, Duval J.
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin].
    Aubert G, Puech C, Lucht F, Loboguerrero M, Denis M, Dorche G.
    Pathol Biol (Paris); 1989 Oct; 37(8):881-7. PubMed ID: 2515519
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [In vitro activity of 4 fluoroquinolones against Klebsiella pneumoniae. Distribution according to phenotype resistance to aminoglycosides or beta-lactams].
    Miguères ML, Ronco E, Guenounou M.
    Pathol Biol (Paris); 1990 May; 38(5):385-9. PubMed ID: 2195447
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [In vitro antibacterial activity of lomefloxacin, a new fluoroquinolone, against hospital strains. Results of a multicenter study].
    Soussy CJ, Le Van Thoi J, Morel C, Acar JF, Thabaut A, Fleurette J, Vallée E, Dabernat H, Chanal M, Drugeon H.
    Pathol Biol (Paris); 1990 May; 38(5):390-6. PubMed ID: 2195448
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [In vitro antibacterial activity of a new fluoroquinolone, temafloxacin, against hospital isolates. Results of a multicenter study].
    Soussy CJ, Morel C, Kitzis MD, Meyran M, Brun Y, Joly-Guillou ML, Dabernat H, Chanal M, Courtieu AL, Derlot E.
    Pathol Biol (Paris); 1991 May; 39(5):403-9. PubMed ID: 1881670
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H, Quentin C, de Barbeyrac B, Bebear C.
    Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
    [Abstract] [Full Text] [Related]

  • 14. [In vitro antibacterial activity of a new fluoroquinolone, fleroxacin as a function of the sensitivity or resistance to nalidixic acid and to pefloxacin].
    Soussy CJ, Leclercq R, Deforges L, Duval J.
    Pathol Biol (Paris); 1989 May; 37(5):364-9. PubMed ID: 2506511
    [Abstract] [Full Text] [Related]

  • 15. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO, Izard D, Bryskier A, Leclerc H.
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.